Categories: HealthcareNews

Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

RADNOR, Pa., Nov. 20, 2024 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m. Eastern Standard Time.

To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor’s website, ir.avantorsciences.com. A replay of the webcast will be available for 30 days.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

View original content:https://www.prnewswire.com/news-releases/avantor-to-participate-in-the-7th-annual-evercore-isi-healthconx-conference-302310579.html

SOURCE Avantor and Financial News

Staff

Recent Posts

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone…

4 minutes ago

AI-Driven Personalized Nutrition and Wellness Solutions Market worth USD 17,867.16 MN by 2032 | Credence Research

LONDON, Dec. 4, 2025 /PRNewswire/ -- The global AI-Driven Personalized Nutrition and Wellness Solutions Market…

3 hours ago

Shinoda Dental Signs MOU with Global Milling Manufacturer, Expands CAD/CAM Portfolio with Leading Brands

With expanded access to brands like Planmeca, Roland, Dentsply Sirona, and Ivoclar, Shinoda Dental becomes…

3 hours ago

BLACK PASTORS UNITED FOR EDUCATION (BPUE) WINS THE 2025 GREGOR G. PETERSON PRIZE IN VENTURE PHILANTHROPY

HARRISBURG, Pa., Dec. 3, 2025 /PRNewswire/ -- Black Pastors United for Education (BPUE), a faith-based…

9 hours ago

Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic…

9 hours ago

ASPN Pharmacies Achieves Surescripts® RxTransfer Certification

FLORHAM PARK, N.J., Dec. 3, 2025 /PRNewswire/ -- ASPN Pharmacies, a leading patient services hub…

9 hours ago